Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP & Chief Medical Officer
-
Issuer Symbol
-
KPTI on Nasdaq
Reshma Rangwala - trading volume in the past year for Karyopharm Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
56,739 |
$533,885 |
$9.41 |
02 Mar 2026 |
Direct |
|
|
| Stock Option (right to buy) |
9,166 |
|
|
28 Feb 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.